close

Enter

Log in using OpenID

Biosimilar Pipeline Analysis MarketBiosimilar Pipeline Analysis Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2025

embed
Biosimilar is a type of biological product that is almost identical to the original product, which has undergone patent expiration. Development and validation of biosimilars are an important part of the overall production process. Regulation for bio
BIOSIMILAR PIPELINE ANALYSIS
MARKET
Global Industry Insights, Trends, Outlook, and
Opportunity Analysis, 2017-2025
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Biosimilar Pipeline Analysis Market Overview
Biosimilar is a type of biological product that is almost identical to the original product, which
has undergone patent expiration. Development and validation of biosimilars are an important
part of the overall production process. Regulation for biosimilar drugs plays an important role in
maintaining the efficiency and balance between original and biosimilar drugs. There are various
authorities such as U.S. Food and Drug Administration (FDA) and European Medicines Agency
(EMA), which regulate the development and commercialization of biosimilars. Biosimilar drugs
are available at relatively low prices as compared to patented drugs without compromising on
efficacy.
Request Sample Copy of the Business Report:
https://www.coherentmarketinsights.com/insight/request-sample/582
Biosimilar has a complex structure, multi-layer manufacturing and immunogenicity risk due to
which they require unique regulatory pathways for introduction in the market. Biosimilar
ensures treatment of diseases considered to be incurable such as cancer and autoimmune
disorders, they are developed independently and have same mechanism of action as patented
drugs for the specific disease. There are different stages involved in the development of
biosimilars such as product development, process development, clinical trial and regulatory
approval and review.
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
• Biosimilar pipeline analysis market taxonomy:
• By Product Type
• Human Growth Hormone
• Insulin
• Interferon
• Peptides
• Monoclonal antibodies
• Others
• By Services
• Clinical Trials
• Contract Research and Manufacturing
Request a Customization:
https://www.coherentmarketinsights.com/insight/request-customization/582
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Patent expiration and low pricing is expected to fuel the biosimilar pipeline analysis market
Biosimilar market is under the initial phase of development, they are used for the treatment of
various disorders such as autoimmune disease, cancer as per National Institute of Health 2012 report,
there were more than 23.5 million people living with autoimmune disease in the U.S. and low pricing
of biosimilar drugs make them affordable for people. The same mechanism of action provides
effective treatment for disease along with increased awareness among people are expected to fuel
the growth of biosimilar pipeline market. Various companies and their R&D departments such as
Pfizer Inc., Zydus Cadila are involved in the development of biosimilar, which is under clinical trial.
Pfizer’s biosimilar clinical stage pipeline includes five monoclonal antibodies fare under clinical trial
phase I to phase 3 which will be used for the treatment of autoimmune disease and oncology.
Get Exclusive Discount on this CMI Report:
https://www.coherentmarketinsights.com/insight/request-discount/582
Key players of biosimilar pipeline analysis market
There are various players present across the world and competing with each other extensively
in the market to attain maximum share. Companies are also involved in R&D to increase the
biosimilar pipeline. Some key players are Biocon, Pfizer Inc., F. Hoffmann-La Roche Ltd, Amgen
Inc., Kyowa Pharmaceutical Industry Co. Ltd, Boehringer Ingelheim GmbH, AstraZeneca,
Novartis AG, and Merck & Co.
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS
ABOUT US
Coherent Market Insights is a global market intelligence and consulting organization focused on
assisting its plethora of clients achieve transformational growth by helping them make critical business
decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our
client base includes players from across all business verticals in over 150 countries worldwide. We are
uniquely positioned to help businesses around the globe deliver practical and lasting results through
various recommendations about operational improvements, technologies, emerging market trends and
new working methods. We offer both customized and syndicated market research reports that help our
clients create visionary growth plans to provide traction to their business. We meticulously study
emerging trends across various industries at both the global and regional levels to identify new
opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
CUSTOMIZED
RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE
SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC
STUDIES
© Coherent market Insights. All Rights Reserved
ABOUT CMI
SECTOR COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS
 Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry
 Component Providers and System Integrators
 Private and Government organization
 Distributors, Retailors and Value Added Resellers
 Outsourcing Companies
 Healthcare IT Solutions Developers
 Universities and Business Schools.
© Coherent market Insights. All Rights Reserved
KEY STATS
RESEARCH SOLUTIONS
100+
FEASIBILITY
STUDIES
Insights Published
Per Year
GLOBAL
REPORTS
150+
Consulting Projects
Till Date
COUNTRY
ANALYSIS
CONSULT
PROJECTS
125+
Clients Worldwide
Per Year
110+
SURVEY
RESEARCH
EXCEL
FORECAST
DATABASE
CUSTOMIZED
SOLUTIONS
COMPETITIVE
ASSESSMENT
TECHNOLOGY
SNIPPETS
Analysts and Contract
Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals,
including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in
order to result in the best possible market research reports across various industries worldwide. Based on our unmatched
expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better
outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure
sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of
opportunities posed therein.
© Coherent market Insights. All Rights Reserved
THANK YOU
To know more about us, visit our website:
www.coherentmarketinsights.com
For sales queries or new topics email us on:
[email protected]
For other queries contact:
Mr. Shah
(Manager - Business Development)
Coherent Market Insights
[email protected]
+1-206-701-6702
© Coherent market Insights. All Rights Reserved
1/--pages
Report inappropriate content